Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

McKesson
Queensland Health
Federal Trade Commission
Deloitte
Fuji
Accenture
Farmers Insurance
Daiichi Sankyo
Colorcon
Novartis

Generated: August 22, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 083855

« Back to Dashboard
NDA 083855 describes TRICHLORMETHIAZIDE, which is a drug marketed by Par Pharm, Watson Labs, Impax Labs, Tg United Labs, and Sandoz, and is included in eleven NDAs. Additional details are available on the TRICHLORMETHIAZIDE profile page.

The generic ingredient in TRICHLORMETHIAZIDE is reserpine; trichlormethiazide. There are nineteen drug master file entries for this compound. Additional details are available on the reserpine; trichlormethiazide profile page.

Summary for NDA: 083855

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:0
Therapeutic Class:Cardiovascular Agents
Formulation / Manufacturing:see details

Summary for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength4MG
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Medtronic
Cerilliant
Healthtrust
Dow
Express Scripts
Harvard Business School
Chinese Patent Office
AstraZeneca
Federal Trade Commission
Farmers Insurance

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot